GH Research PLC (GHRS)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT05757869 A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation PHASE3 Active Not Recruiting 20,284

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for GHRS.

SEC EDGAR Filings

All SEC filings for GH Research PLC on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.